Clinical Development Strategy & Execution
We are developing a pipeline of allogeneic cell therapies using the lymph node as an in vivo bioreactor to grow functioning ectopic organs.
- LiverEnd Stage Liver DiseasePhase 2A
- ThymusAgingPOC Completed
- KidneysEnd Stage Renal DiseasePOC Completed
- PancreasType 1 DiabetesPOC Completed
Our lead therapy is indicated for patients with End Stage Liver Disease, while our other therapies focus on Type 1 diabetes, end stage renal disease, aging, and auto-immune diseases.